Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Aug;27(4):e14143.
doi: 10.1111/hex.14143.

Patient Perspectives on a Patient-Facing Tool for Lung Cancer Screening

Victoria L Tiase  1 , Grace Richards  2 , Teresa Taft  1 , Leticia Stevens  1 , Christian Balbin  1 , Kimberly A Kaphingst  3 , Angela Fagerlin  4 , Tanner Caverly  5 , Polina Kukhareva  1 , Michael Flynn  6 , Jorie M Butler  1 , Kensaku Kawamoto  1
Affiliations

Patient Perspectives on a Patient-Facing Tool for Lung Cancer Screening

Victoria L Tiase et al. Health Expect. 2024 Aug.

Abstract

Background: Individuals with high risk for lung cancer may benefit from lung cancer screening, but there are associated risks as well as benefits. Shared decision-making (SDM) tools with personalized information may provide key support for patients. Understanding patient perspectives on educational tools to facilitate SDM for lung cancer screening may support tool development.

Aim: This study aimed to explore patient perspectives related to a SDM tool for lung cancer screening using a qualitative approach.

Methods: We elicited patient perspectives by showing a provider-facing SDM tool. Focus group interviews that ranged in duration from 1.5 to 2 h were conducted with 23 individuals with high risk for lung cancer. Data were interpreted inductively using thematic analysis to identify patients' thoughts on and desires for a patient-facing SDM tool.

Results: The findings highlight that patients would like to have educational information related to lung cancer screening. We identified several key themes to be considered in the future development of patient-facing tools: barriers to acceptance, preference against screening and seeking empowerment. One further theme illustrated effects of patient-provider relationship as a limitation to meeting lung cancer screening information needs. Participants also noted several suggestions for the design of technology decision aids.

Conclusion: These findings suggest that patients desire additional information on lung cancer screening in advance of clinical visits. However, there are several issues that must be considered in the design and development of technology to meet the information needs of patients for lung cancer screening decisions.

Patient or public contribution: Patients, service users, caregivers or members of the public were not involved in the study design, conduct, analysis or interpretation of the data. However, clinical experts in health communication provided detailed feedback on the study protocol, including the focus group approach. The study findings contribute to a better understanding of patient expectations for lung cancer screening decisions and may inform future development of tools for SDM.

Keywords: cancer screening tests; decision aid; informatics; lung cancer; patient preferences; shared decision‐making.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Decision precision lung cancer screening risk calculator (screenlc.com).
See this image and copyright information in PMC

Similar articles

See all similar articles

References

    1. “Lung Cancer ,” World Health Organization, accessed November 1, 2023, https://www.who.int/news-room/fact-sheets/detail/lung-cancer.
    1. Weintraub K., “Lung Cancer Screening Saves Lives. So Why Do So Few of Those at Risk Get One?” accessed October 16, 2023, https://www.usatoday.com/story/news/health/2022/11/15/lung-cancer-screen....
    1. “Final Recommendation Statement: Lung Cancer Screening ,” US Preventive Services Task Force, accessed October 16, 2023, https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/lung....
    1. Kovalchik S. A., Tammemagi M., Berg C. D., et al., “Targeting of Low‐Dose CT Screening According to the Risk of Lung‐Cancer Death,” New England Journal of Medicine 369, no. 3 (July 2013): 245–254, 10.1056/NEJMoa1301851. - DOI - PMC - PubMed
    1. Wender R., Fontham E. T. H., Barrera E., et al., “American Cancer Society Lung Cancer Screening Guidelines,” CA: A Cancer Journal for Clinicians 63, no. 2 (2013): 106–117, 10.3322/caac.21172. - DOI - PMC - PubMed

Publication types